A family physician is reviewing a promotional brochure for a newly approved oral anti-obes… — USMLE Step 3

A family physician is reviewing a promotional brochure for a newly approved oral anti-obesity medication. The brochure prominently features a bar chart demonstrating a " $25\%$ reduction in total body weight at $12$ months" ( $p < 0.001$ ) compared to placebo.

Upon reading the methodology section in the fine print, the physician notes that the randomized controlled trial initially enrolled $2,000$ participants ( $1,000$ in the treatment arm and $1,000$ in the placebo arm). However, the final efficacy analysis only included the $400$ patients in the treatment arm and $600$ patients in the placebo arm who completed all scheduled clinic visits over the $12$ -month period. The text states that the majority of participants who did not complete the study in the treatment arm withdrew early due to intolerable gastrointestinal side effects.

Based on the trial's methodology, which of the following best describes the primary threat to the validity of the advertisement's efficacy claim?

A
The primary flaw is the failure to use a Chi-square test to appropriately adjust for the participants who withdrew from the study.
The efficacy claim is likely overestimated due to attrition bias, as the analysis excluded patients who could not tolerate the medication.Answer
C
The unequal dropout rate between the two arms artificially decreases the positive predictive value of the primary endpoint.
D
The researchers committed premature closure by analyzing the data at $12$ months rather than waiting for long-term cardiovascular outcomes.
E
The high rate of gastrointestinal side effects establishes an absolute contraindication, invalidating the statistical significance of the weight loss.

Answer

The efficacy claim is likely overestimated due to attrition bias, as the analysis excluded patients who could not tolerate the medication.

The trial exhibits a severe case of attrition bias (loss to follow-up bias). In randomized controlled trials, if a significant number of participants drop out, and especially if the dropout rates differ between the treatment and placebo arms (differential attrition), the remaining participants may no longer be representative of the original randomized groups. The advertisement bases its

25\%

weight loss claim on a 'per-protocol' analysis (only those who completed the study). Because

60\%

of the treatment arm dropped out largely due to adverse effects, those who remained were likely the ones who tolerated the drug best and potentially had the best outcomes. This violates the principle of randomization and artificially inflates the drug's apparent efficacy. An intention-to-treat (ITT) analysis, which includes all patients originally randomized regardless of completion, is the standard for avoiding this bias.

Step-by-Step Solution

Analyze the trial's enrollment and completion numbers.

The trial enrolled

2,000

patients but only analyzed

1,000

(

400

in treatment,

600

in placebo). This represents a massive

50\%

overall dropout rate, with disproportionate dropouts in the treatment arm (

60\%

40\%

To identify discrepancies between the enrolled population and the analyzed population.

Determine the type of analysis used by the researchers.

By only analyzing patients who completed all clinic visits, the researchers utilized a 'per-protocol' analysis rather than an 'intention-to-treat' (ITT) analysis.

To understand how the missing data was handled statistically.

Identify the epidemiological bias introduced by this methodology.

The exclusion of dropouts, especially those who left due to adverse effects, introduces attrition bias. This selectively removes patients who likely failed the therapy, leading to an overestimation of the drug's true efficacy in a real-world setting.

To evaluate the validity of the advertisement's clinical claims.

Key Concept

Identifying attrition bias and the importance of Intention-To-Treat (ITT) analysis in randomized controlled trials.

Estimated Time:1m 30s

Question

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Topics

More questions from this topic